Table 3

Mean MI by participant

TreatmentTimeMean ± SERange
4-HPR (n = 34)Baseline38.9 ± 3.7(0–100)
6 months31.8 ± 4.6(0–83.3)
Change over timea−7.1 ± 4.7(−60–50)
Placebo (n = 36)Baseline43.7 ± 4.2(10–100)
6 months38.8 ± 5.2(0–100)
Change over timea−4.9 ± 3.1(−33.4–48.3)
  • a Change of mean MI between 4-HPR and placebo groups: P = 0.79, two-sided Wilcoxon’s rank-sum test.